Cargando…

Interleukin-18 serum level is elevated in type 2 diabetes and latent autoimmune diabetes

BACKGROUND: Interleukin-18 (IL-18) is an inflammatory cytokine found to be elevated in obesity, metabolic syndrome and type 2 diabetes (T2D) as a part of the chronic low-grade inflammatory process in these states. The aim of the study was to evaluate the interleukin level in patients with latent aut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaharieva, Emanuela, Kamenov, Zdravko, Velikova, Tsvetelina, Tsakova, Adelina, El-Darawish, Yosif, Okamura, Haruki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776671/ https://www.ncbi.nlm.nih.gov/pubmed/29217651 http://dx.doi.org/10.1530/EC-17-0273

Ejemplares similares

Prevalence of Positive Diabetes-Associated Autoantibodies among Type 2 Diabetes and Related Metabolic and Inflammatory Differences in a Sample of the Bulgarian Population
por: Zaharieva, Emanuela Tsvetkova, et al.
Publicado: (2017)

Elevated levels of interleukin-18 are associated with several indices of general and visceral adiposity and insulin resistance in women with polycystic ovary syndrome
por: Kabakchieva, Plamena, et al.
Publicado: (2022)

Physiological and molecular effects of interleukin-18 administration on the mouse kidney
por: Yamanishi, Kyosuke, et al.
Publicado: (2018)

Deficiency in interleukin-18 promotes differentiation of brown adipose tissue resulting in fat accumulation despite dyslipidemia
por: Yamanishi, Kyosuke, et al.
Publicado: (2018)

Effectiveness and Tolerability of Second-Line Therapy with Vildagliptin Versus Other Oral Agents in Type 2 Diabetes (EDGE): Post Hoc Sub-Analysis of Bulgarian Data
por: Kamenov, Zdravko
Publicado: (2014)

SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis
por: Velikova, Tsvetelina, et al.
Publicado: (2021)

Stress Hyperglycemia, Diabetes Mellitus and COVID-19 Infection: Risk Factors, Clinical Outcomes and Post-Discharge Implications
por: Gerganova, Antonina, et al.
Publicado: (2022)

Latent autoimmune diabetes in adults in China
por: Qiu, Junlin, et al.
Publicado: (2022)

Neuropilin‐1 (NRP1) expression distinguishes self‐reactive helper T cells in systemic autoimmune disease
por: Raveney, Ben JE, et al.
Publicado: (2022)

Diabetic Ketoacidosis as First Presentation of Latent Autoimmune Diabetes in Adult
por: Nadhem, Omar, et al.
Publicado: (2015)

Body Composition Indices and Cardiovascular Risk in Type 2 Diabetes. CV Biomarkers are not Related to Body Composition
por: Markova, Aleksandra, et al.
Publicado: (2020)

Latent autoimmune diabetes of adulthood: case report
por: Page, Cristen P., et al.
Publicado: (2017)

An Atypical Case of Latent Autoimmune Diabetes of Adults
por: Kim, Keun Young, et al.
Publicado: (2021)

Editorial: Latent Autoimmune Diabetes in Adults (LADA)
por: Leslie, Richard David
Publicado: (2022)

A Review on Latent Autoimmune Diabetes in Adults
por: Ravikumar, Vijay, et al.
Publicado: (2023)

Placental Growth Factor and Pregnancy-Associated Plasma Protein-A as Potential Early Predictors of Gestational Diabetes Mellitus
por: Yanachkova, Vesselina, et al.
Publicado: (2023)

Latent Autoimmune Diabetes in Adults: Autoimmune Diabetes in Adults with Slowly Progressive β-cell Failure
por: Seok, Hannah, et al.
Publicado: (2012)

Clinical features of childhood diabetes mellitus focusing on latent autoimmune diabetes
por: Lee, Seung Ho, et al.
Publicado: (2016)

SUN-124 Latent Autoimmune Diabetes of the Adult (LADA): Is It Gestational Diabetes?
por: Cruz Dardiz, Nicolas, et al.
Publicado: (2019)

COVID-19-Induced Diabetic Ketoacidosis in an Adult with Latent Autoimmune Diabetes
por: Omotosho, Yetunde B, et al.
Publicado: (2021)

Latent Autoimmune Diabetes in an Adult Male Presenting With Diabetic Ketoacidosis (DKA)
por: Imam, Syed K, et al.
Publicado: (2023)

Characteristics and Prevalence of Latent Autoimmune Diabetes in Adults (LADA)
por: Brahmkshatriya, Priyanka P., et al.
Publicado: (2012)

Latent autoimmune diabetes of the adult: current knowledge and uncertainty
por: Laugesen, E, et al.
Publicado: (2015)

Recognizing and Appropriately Treating Latent Autoimmune Diabetes in Adults
por: O’Neal, Katherine S., et al.
Publicado: (2016)

Serum Bile Acid Profiles in Latent Autoimmune Diabetes in Adults and Type 2 Diabetes Patients
por: Zhou, Yu, et al.
Publicado: (2022)

Targeting Inflammatory Cytokines to Improve Type 2 Diabetes Control
por: Velikova, Tsvetelina V., et al.
Publicado: (2021)

COVID-19 Vaccines for Adults and Children with Autoimmune Gut or Liver Disease
por: Peshevska-Sekulovska, Monika, et al.
Publicado: (2022)

Sepsis in Latent Autoimmune Diabetes in Adults with Diabetic Ketoacidosis: A Case Report
por: Rahmadi, Afdol, et al.
Publicado: (2019)

Effectiveness and safety of COVID-19 vaccines in patients with diabetes as a factor for vaccine hesitancy
por: Vasilev, Georgi, et al.
Publicado: (2022)

β-Cell Protection and Therapy for Latent Autoimmune Diabetes in Adults
por: Cernea, Simona, et al.
Publicado: (2009)

Fatty fish consumption and risk of latent autoimmune diabetes in adults
por: Löfvenborg, J E, et al.
Publicado: (2014)

Small Fiber Neuropathy in Patients With Latent Autoimmune Diabetes in Adults
por: Alam, Uazman, et al.
Publicado: (2015)

Latent Autoimmune Diabetes in Adults: Current Status and New Horizons
por: Pozzilli, Paolo, et al.
Publicado: (2018)

A Case of Late Diagnosis of Latent Autoimmune Diabetes in Adults
por: Costa, Joana R, et al.
Publicado: (2022)

Latent Autoimmune Diabetes in Adults (LADA): From Immunopathogenesis to Immunotherapy
por: Hu, Jingyi, et al.
Publicado: (2022)

COVID-19 Vaccine-Induced Latent Autoimmune Diabetes in Adults
por: Bally, Klynt, et al.
Publicado: (2023)

Etiology and Pathogenesis of Latent Autoimmune Diabetes in Adults (LADA) Compared to Type 2 Diabetes
por: Carlsson, Sofia
Publicado: (2019)

Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine
por: Velikova, Tsvetelina, et al.
Publicado: (2023)

Interleukin-6 and Interleukin-15 as Possible Biomarkers of the Risk of Autoimmune Diabetes Development
por: Siewko, Katarzyna, et al.
Publicado: (2019)

Challenges and updates in the management of eosinophilic esophagitis
por: Velikova, Tsvetelina
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8k8nnprnn9smj0tmssf57fuqq5